Stay updated on SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial page.

Latest updates to the SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedAdded a Locations section listing Missouri and updated the revision to v3.3.3. Removed the HHS Vulnerability Disclosure and the Missouri Locations header (older revision).SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedPublications section wording was updated to indicate entries are automatically filled from PubMed and may not all pertain to the study; the revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check43 days agoChange DetectedRemoval of a site-wide government funding lapse notice from the page; no changes to the study's details, eligibility criteria, or endpoints. The page's primary content remains the study description, eligibility criteria, and trial design. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check57 days agoChange DetectedNo additions or deletions were detected on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check86 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check93 days agoChange DetectedMetadata and personnel/version updates: adding Carl DeSelm, M.D., Ph.D. and updating to Revision v3.1.0; removing Hyun Kim, M.D. and older update stamps (Last Update Posted, 2025-06, v3.0.2).SummaryDifference0.9%

Stay in the know with updates to SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial page.